Fluoxetine and Side Effects

Archives of General Psychiatry

Volumn 47, Issue 2, 1990, Pages 191-192

  Baldessarini, Ross J ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; FLUOXETINE;

ANIMAL EXPERIMENT; AUTOPSY; BRAIN CORTEX; EXTRAPYRAMIDAL SYMPTOM; HISTOCHEMISTRY; LETTER; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; BRAIN; BRAIN CHEMISTRY; DIHYDROXYPHENYLALANINE; DOPAMINE; FLUOXETINE; HUMAN; RATS; RATS, INBRED STRAINS; SEROTONIN;

EID: 0025189992     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1990.01810140091015     Document Type: Letter

References (5)

1. Bouchard RH, Pourcher E, Vincent P. Fluoxetine and extrapyramidal side effects. Am J Psychiatry. 1989;146:1352-1353.
2. Tate JL. Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine. Am J Psychiatry. 1989;146:399-400.
3. Goodnick PJ. Influence of fluoxetine on plasma levels of desipramine. Am J Psychiatry. 1989;146:552.
4. Baldessarini RJ, Marsh E, Kula NS, Neumeyer JL. Effects of mono- and dihydroxyaporphines on dopamine metabolism in rat brain regions. Biochem Pharmacol. In press.
5. Roth RH, Wolf ME, Deutch AY. Neurochemistry of midbrain dopamine systems. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press, 1987:81-94.